Boundless Bio, Inc.
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 127.15M | 138.25M | 152.11M | 167.14M | 179.29M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 2.54M | 2.11M | 2.28M | 2.81M | 3.84M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | 500.00K | -- |
Total Current Assets | 129.69M | 140.36M | 154.39M | 170.45M | 183.13M |
|
|||||
Total Current Assets | 129.69M | 140.36M | 154.39M | 170.45M | 183.13M |
Net Property, Plant & Equipment | 49.16M | 50.27M | 51.36M | 4.07M | 4.49M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 604.00K | 610.00K | 659.00K | 576.00K | 578.00K |
Total Assets | 179.45M | 191.24M | 206.41M | 175.09M | 188.20M |
|
|||||
Total Accounts Payable | 2.29M | 1.37M | 1.27M | 2.54M | 1.69M |
Total Accrued Expenses | 4.96M | 4.71M | 6.86M | 7.35M | 6.43M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.96M | 262.00K | -- | 121.00K | 837.00K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 9.21M | 6.34M | 8.14M | 10.01M | 8.96M |
|
|||||
Total Current Liabilities | 9.21M | 6.34M | 8.14M | 10.01M | 8.96M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 47.55M | 48.31M | 47.63M | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 56.76M | 54.65M | 55.77M | 10.01M | 8.96M |
|
|||||
Common Stock & APIC | 355.60M | 353.79M | 351.99M | 349.87M | 347.83M |
Retained Earnings | -232.91M | -217.23M | -201.47M | -185.02M | -168.52M |
Treasury Stock & Other | -4.00K | 32.00K | 121.00K | 236.00K | -64.00K |
Total Common Equity | 122.69M | 136.59M | 150.64M | 165.08M | 179.25M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 122.69M | 136.59M | 150.64M | 165.08M | 179.25M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 122.69M | 136.59M | 150.64M | 165.08M | 179.25M |
|